Antipruritic effect of macrolide antibiotics

Journal of Dermatology

Volumn 27, Issue 1, 2000, Pages 66-67

  Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; MACROLIDE; ROXITHROMYCIN;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; LETTER; MALE; PRURITUS; PSORIASIS VULGARIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; DERMATITIS, ATOPIC; FEMALE; HUMANS; MACROLIDES; MALE; MIDDLE AGED; PRURIGO; PRURITUS; PSORIASIS;

EID: 0034049674     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2000.tb02123.x     Document Type: Letter

References (5)

1. Takizawa H, Desaki M, Ohtoshi T, et al. Erythromycin suppresses interleukin-6 expression by human bronchial epithelial cells: A potential mechanism of its anti-inflammatory action, Biochem Biophys. Res Commun, 210: 781-786, 1995.
2. Takizawa H, Desaki M, Ohtoshi T, et al. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells, Am J Respir Crit Care Med, 156: 266-271, 1997.
3. Ichikawa Y, Ninomiya H, Katsuki M, et al. Erythromycin reduces neutrophils and neutrophil derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients, Am Rev Respir Dis, 146: 196-203, 1992.
4. Kudoh S, Uetake T, Hagiwara K, et al. Clinical effects of low-dose long term erythromycin chemotherapy on diffuse panbronchiolitis. Nippon Kyobu Shikkan Gakkai Zasshi-Japanese Journal of Thoracic Disease, 25: 632-642, 1987. (in Japanese)
5. Kadota J, Sakito O, Kohno S, et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis, Am Rev Respir Dis, 147: 153-159, 1993.